Using machine learning to enhance prediction of atrial fibrillation recurrence after catheter ablation

Mark S. Brahier,Fengwei Zou,Musa Abdulkareem,Shwetha Kochi,Frank Migliarese,Athanasios Thomaides,Xiaoyang Ma,Colin Wu,Veit Sandfort,Peter J. Bergquist,Monvadi B. Srichai,Jonathan P. Piccini,Steffen E. Petersen,Jose D. Vargas
DOI: https://doi.org/10.1002/joa3.12927
2023-10-07
Journal of Arrhythmia
Abstract:We found that machine learning‐derived, full volumetric LAVi from cardiac computed tomography is the most important pre‐procedural risk factor for late AF recurrence following catheter ablation. The combination of increased LAVi and early recurrence conferred more than a four‐fold increased risk of late recurrence in our retrospective study of 653 patients undergoing catheter ablation for symptomatic, drug refractory atrial fibrillation. Background Traditional risk scores for recurrent atrial fibrillation (AF) following catheter ablation utilize readily available clinical and echocardiographic variables and yet have limited discriminatory capacity. Use of data from cardiac imaging and deep learning may help improve accuracy and prediction of recurrent AF after ablation. Methods We evaluated patients with symptomatic, drug‐refractory AF undergoing catheter ablation. All patients underwent pre‐ablation cardiac computed tomography (cCT). LAVi was computed using a deep‐learning algorithm. In a two‐step analysis, random survival forest (RSF) was used to generate prognostic models with variables of highest importance, followed by Cox proportional hazard regression analysis of the selected variables. Events of interest included early and late recurrence. Results Among 653 patients undergoing AF ablation, the most important factors associated with late recurrence by RSF analysis at 24 (+/−18) months follow‐up included LAVi and early recurrence. In total, 5 covariates were identified as independent predictors of late recurrence: LAVi (HR per mL/m2 1.01 [1.01–1.02]; p 66.7 mL/m2 and early recurrence had the highest risk of late recurrence risk compared with those with LAVi <66.7 mL/m2 and no early recurrence (HR 4.52 [3.36–6.08], p
What problem does this paper attempt to address?